118 related articles for article (PubMed ID: 1878411)
1. N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination.
Garg S; Garg PK; Zalutsky MR
Bioconjug Chem; 1991; 2(1):50-6. PubMed ID: 1878411
[TBL] [Abstract][Full Text] [Related]
2. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(6):387-93. PubMed ID: 2099187
[TBL] [Abstract][Full Text] [Related]
3. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Reist CJ; Garg PK; Alston KL; Bigner DD; Zalutsky MR
Cancer Res; 1996 Nov; 56(21):4970-7. PubMed ID: 8895752
[TBL] [Abstract][Full Text] [Related]
4. Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Reist CJ; Archer GE; Wikstrand CJ; Bigner DD; Zalutsky MR
Cancer Res; 1997 Apr; 57(8):1510-5. PubMed ID: 9108453
[TBL] [Abstract][Full Text] [Related]
5. Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Garg S; Garg PK; Zhao XG; Friedman HS; Bigner DD; Zalutsky MR
Nucl Med Biol; 1993 Oct; 20(7):835-42. PubMed ID: 8241995
[TBL] [Abstract][Full Text] [Related]
6. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
Garg PK; Garg S; Zalutsky MR
Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279
[TBL] [Abstract][Full Text] [Related]
7. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1993; 4(1):78-84. PubMed ID: 8431515
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
[TBL] [Abstract][Full Text] [Related]
9. Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(4):269-73. PubMed ID: 2096920
[TBL] [Abstract][Full Text] [Related]
10. Positively charged templates for labeling internalizing antibodies: comparison of N-succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR.
Foulon CF; Welsh PC; Bigner DD; Zalutsky MR
Nucl Med Biol; 2001 Oct; 28(7):769-77. PubMed ID: 11578897
[TBL] [Abstract][Full Text] [Related]
11. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
12. A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.
Zalutsky MR; Narula AS
Int J Rad Appl Instrum A; 1987; 38(12):1051-5. PubMed ID: 2828275
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody F(ab')2 fragment labeled with N-succinimidyl 2,4-dimethoxy-3-halobenzoates: in vivo comparison of iodinated and astatinated fragments.
Vaidyanathan G; Affleck D; Zalutsky MR
Nucl Med Biol; 1994 Jan; 21(1):105-10. PubMed ID: 9234271
[TBL] [Abstract][Full Text] [Related]
14. Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution.
Zalutsky MR; Xu FJ; Yu Y; Foulon CF; Zhao XG; Slade SK; Affleck DJ; Bast RC
Nucl Med Biol; 1999 Oct; 26(7):781-90. PubMed ID: 10628557
[TBL] [Abstract][Full Text] [Related]
15. Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate.
Vaidyanathan G; Affleck DJ; Bigner DD; Zalutsky MR
Nucl Med Biol; 2002 Jan; 29(1):1-11. PubMed ID: 11786270
[TBL] [Abstract][Full Text] [Related]
16. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
[TBL] [Abstract][Full Text] [Related]
17. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
Zalutsky MR; Narula AS
Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
[TBL] [Abstract][Full Text] [Related]
18. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
Garg PK; Harrison CL; Zalutsky MR
Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501
[TBL] [Abstract][Full Text] [Related]
19. A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB).
Vaidyanathan G; Affleck DJ; Li J; Welsh P; Zalutsky MR
Bioconjug Chem; 2001; 12(3):428-38. PubMed ID: 11353542
[TBL] [Abstract][Full Text] [Related]
20. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
Zalutsky MR; Noska MA; Colapinto EV; Garg PK; Bigner DD
Cancer Res; 1989 Oct; 49(20):5543-9. PubMed ID: 2477144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
